Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q2 2015 · 10-Q
Revenue$1.61M$1.61M+72.6% vs Q2 2014 Net Income$4.45M$4.45MN/M vs Q2 2014 EPS Diluted$0.45$0.45N/M vs Q2 2014 Gross Profit$318,000+88.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flowderived-$4,758,000N/M Free Cash Flowderived-$5,068,000N/M Margins · derivedGross margin19.7%+1.6 pt vs Q2 2014
Operating margin358.9%+1501.6 pt vs Q2 2014
Net margin275.7%+1540.7 pt vs Q2 2014
ended Jun 30, 2015 · filed Aug 10, 2015 · 41 d after period end